M1 Kliniken AG (DE000A0S) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
M1 Kliniken AG

BRIEF

published on 11/19/2024 at 08:20, 2 days 5 hours ago

M1 Kliniken AG Reports 71% Increase in Operating Profit

Private Equity Operating Profit Beauty Segment Financial Growth Strategic Expansion
PRESS RELEASE

published on 11/19/2024 at 08:15, 2 days 5 hours ago

M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets
M1 Kliniken AG reports a 71% increase in operating profit (EBIT) in the first nine months of 2024, with sales up by 8.7%. Medium-term targets confirmed

Operating Profit M1 Kliniken AG Sales Increase Medium-term Targets Beauty Treatments
BRIEF

published on 09/06/2024 at 14:36, 2 months 14 days ago

First Berlin Equity Research Reaffirms BUY Rating for M1 Kliniken AG

First Berlin Equity Research M1 Kliniken AG BUY Rating Beauty Segment Q2 Results
PRESS RELEASE

published on 09/06/2024 at 14:31, 2 months 14 days ago

Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research GmbH has published an update on M1 Kliniken AG, reiterating a Buy rating with a target price of €28. Q2 results show promising growth in injectables business and PE interest in Beauty segment

First Berlin Equity Research M1 Kliniken AG BUY Rating Beauty Segment Q2 Results
BRIEF

published on 09/03/2024 at 08:50, 2 months 18 days ago

M1 Kliniken AG Nearly Doubles Operating Profit in H1 2024

Revenue Growth Private Equity Operating Profit Beauty Segment Expansion Strategy
PRESS RELEASE

published on 09/03/2024 at 08:45, 2 months 18 days ago

Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024
M1 Kliniken AG reports significant growth in first half of 2024 with almost doubled EBIT. Beauty segment leads sales increase. Expansion and profitability continue

Expansion M1 Kliniken AG EBIT Growth Beauty Treatments
BRIEF

published on 06/21/2024 at 12:52, 5 months ago

M1 Kliniken AG: Management Board Confirms Growth Targets

Expansion M1 Kliniken AG Forecast Growth Targets Beauty Market
PRESS RELEASE

published on 06/21/2024 at 12:47, 5 months ago

M1 Kliniken AG: Management Board confirms growth targets
M1 Kliniken AG's Management Board confirms growth targets, including sales growth of up to 30% and EBIT increase of up to 40% in 2024. Strategic plans aim to become a leading provider in the beauty market

Sales Growth M1 Kliniken AG Management Board Growth Targets Beauty Market
BRIEF

published on 06/11/2024 at 16:43, 5 months 9 days ago

M1 Kliniken Announces Management Board Changes and Affirms Long-Term Growth Strategy

Growth Strategy Financial Performance M1 Kliniken AG Management Board Beauty Segment
PRESS RELEASE

published on 06/11/2024 at 16:38, 5 months 9 days ago

M1 Kliniken announces change in the Management Board and confirms long-term growth strategy
M1 Kliniken AG announces change in Management Board as Kilian Brenske steps down and reaffirms long-term growth strategy. Co-CEO Attila Strauss to lead strategic areas alone

Growth Strategy M1 Kliniken AG Management Board Attila Strauss M1 Med Beauty

1 2 ... 4

Accesswire

Published on 11/21/2024 at 13:30, 35 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 35 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 50 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 30 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 50 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 59 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 5 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 7 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 45 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 20 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 20 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE